Lucid Diagnostics Inc.
LUCDNASDAQHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $60.01M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.30$1.63
- Volume (live)
- -
- Avg. volume (3M)
- 3.62M
Lucid Diagnostics (LUCD) Stock Price & Financial Analysis
Lucid Diagnostics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.30 - $0.33 |
|---|---|
| 52-Week High | $1.63 |
| 52-Week Low | $0.30 |
| Open | $0.32 |
| Volume (last close) | 48.10M |
| Average Volume (3M) | 3.62M |
| Revenue (TTM) | 5.45M |
|---|---|
| Net Income (TTM) | -52.26M |
| Free Cash Flow (TTM) | -47.18M |
| EPS (TTM) | −$0.38 |
| Profit Margin | -959.76% |
| Operating Margin | -930.85% |
| Return on Equity (ROE) | -478.26% |
| Debt to Equity | 2.28 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 60.01M |
|---|---|
| Shares Outstanding | 183.12M |
| Price to Sales (P/S) | 11.02 |
| Price to Book (P/B) | 5.49 |
| EV/EBITDA | -1.00 |
| 50-Day MA | $0.81 |
|---|---|
| 200-Day MA | $1.05 |
| 1-Year Change | −73.36% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Lucid Diagnostics at a Glance
As of the Oct 22, 2026 close, Lucid Diagnostics (LUCD) has a market capitalization of $60.01M. The stock trades at 11.0× sales. Over the trailing twelve months it lost $52.26M on revenue of $5.45M and burned $47.18M of free cash flow. Revenue grew 24.9% year over year.
As of its latest reported balance sheet, it holds $33.40M in cash and securities against $24.91M of debt, a net cash position of $8.49M.
Lucid Diagnostics does not currently pay a dividend.
The share price is down 73.4% over the past year. At $0.33 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.30 to $1.63, below its 200-day moving average of $1.05.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $4.25, 1196.9% above the Oct 22, 2026 close.
Frequently Asked Questions About Lucid Diagnostics
What is the current stock price for LUCD?
As of the Oct 22, 2026 close, LUCD stock trades at $0.33. The 52-week range is $0.30–$1.63, with a day range of $0.30–$0.33.
What is the P/E ratio for LUCD?
The P/E ratio (Price-to-Earnings) for LUCD is shown in the Key Statistics section. This valuation metric helps compare Lucid Diagnostics Inc. to industry peers.
Does LUCD pay dividends?
Lucid Diagnostics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LUCD?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for LUCD is Buy. The average 12-month price target is $4.25, a 1196.9% upside from the Oct 22, 2026 close of $0.33.
What is the market cap of LUCD?
As of the Oct 22, 2026 close, Lucid Diagnostics's market capitalization is $60.0M, classifying it as a micro-cap company. Lucid Diagnostics operates in the Healthcare sector within the Medical Devices industry.